The global vitamin D testing market size is projected to register a significant CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the rise in the global geriatric population with increase in chronic illnesses such as kidney disease, type 2 diabetes, celiac disease, and Crohn's disease.
The vitamin D testing involves a screening process to measure how much amount of vitamin D is present in a body. Various illnesses or diseases can be occurred in the body due to vitamin D deficiency such as lupus, rheumatoid arthritis, type 1 diabetes, and inflammatory bowel disease. Some of the main group of individuals who are likely to develop the mentioned diseases or at high risk of vitamin D deficiency include teenagers, pregnant & breast feeding women, children under 5 years of age, and infants. Additionally, those group of people who are above 65 years and are getting no or low sun exposure are more likely to develop one or other diseases due to lack of vitamin D.
Under the initiatives of global health organizations, government authorities have implemented various policies to make people of low-income countries aware about benefits of regular health checkups. Moreover, several health schemes such as Healthy Start Scheme have been introduced in the UK to provide free supplements for low-income families. The deficiency is commonly found across the countries of Northern Europe and occurred especially among women. An important aspect is that people are increasingly aware about this deficiency and rising development of technology advancement for the treatment of the same. Although the deficiency does not cause any immediate illness, the prolonged negligence of vitamin D deficiency can cause serious diseases and any other critical disorders. For this reason, health organizations and healthcare authorities in several developed nations are actively organizing awareness events and campaigns for vitamin D testing to prevent from several diseases.
Market Trends, Drivers, Restraints, and Opportunities
- Rising demand for vitamin D testing due to high occurrence of vitamin D deficiency across the globe is expected to drive the market growth.
- Research and development activities, commercialization of new testing kits, and various government initiatives for public awareness are expected to boost the market growth.
- Development of new advanced screening technology and wide adoption of CLIA technology in testing methods are expected to increase the demand for the testing in the coming years.
- 1, 25 Dihydroxy Vitamin D test is provided by a few companies only and the lack of commercialization and availability of the test in developing regions is expected to hamper the market during the forecast period.
Scope of the Report
The report on the global vitamin D testing market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
| Attributes | Details |
| Report Title | Vitamin D Testing Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
| Base Year | 2020 |
| Historic Data | 2018–2019 |
| Forecast Period | 2021–2028 |
| Segmentation | Types of Test (25-Hydroxy Vitamin D Tests and 1, 25-Dihydroxy Vitamin D Tests) |
| Regional Scope | Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
| Report Coverage | Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
| Key Players Covered in the Report | Abbott Laboratories; Danaher Corporation; F. Hoffmann-La Roche Ltd.; Siemens Corporation, Quest Diagnostics, Inc.; bioMérieux SA; and DiaSorin. |
Market Segment Insights
25–Hydroxy Vitamin D tests segment is expected to grow at a rapid pace
Based on types of test, the global vitamin D testing market is segregated into 25–Hydroxy Vitamin D tests and 1, 25-Dihydroxy Vitamin D tests. The 25 –Hydroxy Vitamin D tests segment is expected to grow at a rapid pace during the forecast period as it is most commonly used testing process due to its wide successful commercialization of the testing. Additionally, the testing type offers higher life compared to other and are mostly recommended by the physicians. However, the 1, 25-Dihydroxy Vitamin D tests segment is anticipated to accounts for a key share of the market in the coming years due to recent development of CLIA technology.
North America is anticipated to constitute a key market share
In terms of regions, the global vitamin D testing market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to constitute a key market share during the forecast period owing to the presence of key players and high awareness about regular health checkups in the region. On the other hand, the market of Asia Pacific is anticipated to grow at a rapid pace during the forecast period due to increase healthcare policies from major economies such as India and rise in expenditure on the healthcare sector.
Segments
Segments Covered in the Report
The global vitamin D testing market has been segmented on the basis of
Types of Test
- 25-Hydroxy Vitamin D Tests
- 1, 25-Dihydroxy Vitamin D Tests
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Abbott Laboratories
- Danaher Corporation
- F. Hoffmann-La Roche Ltd.
- Siemens Corporation, Quest Diagnostics, Inc.
- bioMérieux SA
- DiaSorin
Competitive Landscape
Key players competing in the global vitamin D testing market are Abbott Laboratories; Danaher Corporation; F. Hoffmann-La Roche Ltd.; Siemens Corporation, Quest Diagnostics, Inc.; bioMérieux SA; and DiaSorin.
Request For Customization
Enquiry Before Buying
Speak With Analyst
